Intra-tumoral bacteria in breast cancer and intervention strategies
- 18 January 2025
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 217, 115516
Abstract
No abstract availableKeywords
Funding Information
- Guangzhou Municipal Science and Technology Bureau (202206010068)
- National Natural Science Foundation of China (22275081)
- National Key Research and Development Program of China (2021YFC2400600/2021YFC2400602)
This publication has 108 references indexed in Scilit:
- Inulin‐Based Nanoparticle Modulates Gut Microbiota and Immune Microenvironment for Improving Colorectal Cancer TherapyAdvanced Functional Materials, 2024
- Probio‐M9, a breast milk‐originated probiotic, alleviates mastitis and enhances antibiotic efficacy: Insights into the gut–mammary axisiMeta, 2024
- Epigenetic regulation of breast cancer metastasisCancer and Metastasis Reviews, 2023
- Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving ChemotherapyJAMA Network Open, 2023
- Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategiesActa Pharmaceutica Sinica B, 2023
- Dual‐Cascade Responsive Nanoparticles Enhance Pancreatic Cancer Therapy by Eliminating Tumor‐Resident Intracellular BacteriaAdvanced Materials, 2022
- 1725P Metastasis-resident bacteria in advanced hormone receptor-positive breast cancer are related to primary tumor microbiota and show distinct compositionAnnals of Oncology, 2022
- The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancerCancer and Metastasis Reviews, 2021
- Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiomeAdvanced Drug Delivery Reviews, 2021
- Bacteriophage-mediated modulation of microbiota for diseases treatmentAdvanced Drug Delivery Reviews, 2021